Calyx and Invicro are now Perceptive
Independent review of trial event assessments by adjudication experts.
Proven expertise in delivering high-quality imaging data at a global scale.
With strengths in instrument engineering, signal processing, and pharmaceutical R&D, Perceptive Discovery consistently delivers successful imaging study designs and executions.
Effective RTSM, built on 30 years of experience, and connected to an ecosystem which includes eConsent and eCOA.
Highly established imaging centers for first-in-human and multicenter trials.
900+ agents radiolabeled and counting.
Supporting both malignant and non-malignant indications.
Experts in Alzheimer’s Disease, Parkinson’s Disease imaging and more.
Supporting over 85% of radiopharmaceutical companies.
Optimize preclinical and clinical trials in other areas and drug classifications.
Therapeutic and technical expertise in imaging modalities, protocol design, and acquisition.
Oncology imaging, RTSM, and clinical adjudication services.
Tackling unique rare disease trial supply, imaging and adjudication challenges.
We are here to serve science.
From discovery, through early to late-phase clinical development, to regulatory approval and post-market, you can count on Perceptive to be dependable, diligent, and driven in everything we do.
Perceptive Discovery bridges preclinical insights to early clinical success, ensuring rigorous scientific analysis and high-quality data to support innovation.
Providing the right-fit randomization & trial supply management solution for your trials, delivered by experts.
The right people, experience, and technology to drive clinical trial imaging success.
Proven expertise in delivering high-quality clinical trial imaging data at a global scale.
We combine deep medical and operational expertise to deliver clinical trial imaging biomarkers across key therapeutic areas such as oncology, neuroscience, and radiopharmaceutical therapy.
Qualified imaging sites and centers across the globe
Clinical trials supported
Expert reader network
Regulatory approvals supported
From first-in-human studies to Phase IV global studies, Perceptive is the world’s leading CNS imaging solution provider.
Perceptive is a trusted partner in oncology imaging, having supported over 2,000 clinical trials across solid tumor and hematological malignancy indications.
Validated Criteria Examples
Modified for Immuno-oncology
Our image analysis team also specializes in developing and applying a broad range of tools to support advanced quantitative oncology tracer characterization and analytics across numerous clinical trial imaging modalities and studies including dosimetry services and biomathematical modeling.
Having supported over 85% of radioligand therapy (RLT) and theranostics companies, Perceptive is the leading service provider for radiopharmaceutical development.
When tackling the many challenges involved in Musculoskeletal (MSK) trial imaging, global clinical trial sponsors repeatedly turn to Perceptive for the right experience, people, processes, and technology to drive their MSK development program’s success.
Having supported over 360 hematology trials across malignant and non-malignant conditions, Perceptive combines deep expertise and global collaboration to support every stage of hematology clinical trials, from thorough protocol consultation to regulatory success:
Perceptive offers proactive, collaborative study management and scientific support to ensure seamless, timely execution of clinical imaging core lab workflows:
Leverage scientific and regulatory expertise to develop tailored imaging protocols.
Site training, investigator meetings, and qualification for standardized trial readiness.
21 CFR Part 11 compliant platforms for submission, quality control, and data tracking.
Subspecialty readers ensure consistent, expert image assessments.
Advanced analytics and validated workflows for modality-specific insights.
Regulatory-compliant data delivery for efficient submissions.
Final data transfer including images and minutes.
Perceptive partners with leading institutions to select subspecialty radiologists, neuroradiologists, and oncologists for our reader programs.
We have a dedicated team that qualifies and selects readers to ensure that we have the most experienced professionals available and trained according to your specific project needs. Reads can be performed either as rolling reads as time points come in or batched and read as subjects come off study.
Additionally, with our expert team of in-house board-certified radiologists and oncologists delivering consistent evaluation, we’re able to ensure the highest standards of image and clinical data analysis. We leverage various reviewer performance monitoring methods and adhere to rigorous quality control processes with independent blinded image and clinical data reviews to support innovative treatments.
Your work is global and so are we. With local support in China, India, Europe, and North America, you can have confidence that your research and clinical trials will run smoothly and deliver high-quality data you can rely on every time.
Our client delivery teams anticipate your needs and scale our services to deliver quick and reliable continuity of service, ensuring efficient site setup to meet your timelines and providing dedicated teams for quality control support.
Reach out today and one of our solution experts will be in touch to learn about your specific needs.
